Ferring launches Lysteda in US for heavy menstrual bleeding
This article was originally published in Scrip
Executive Summary
Ferring Pharmaceuticals has launched Lysteda (tranexamic acid) tablets in the US for the treatment of women with cyclic heavy menstrual bleeding (HMB), or menorrhagia.